6794.TW
Price:
$80.6
Market Cap:
$4.81B
UnicoCell Biomed Co., Ltd. engages in the research and development of stem cell drugs, cell therapy technology, and regenerative medical services in Taiwan. It develops ELIXCYTE, which is in Phase 2 clinical trials for the treatment of osteoarthritis and chronic kidney disease. The company offers UnicoVial, a cryotube and drug container for cell therapy products, as well as provides testing services. UnicoCell Biomed Co., Ltd. is based in Taipei, Taiwan.
Industry
Biotechnology
IPO Date
2024-05-13
Stock Exchange
TAI
Ticker
6794.TW
According to UnicoCell Biomed Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -45.03. This represents a change of 94.39% compared to the average of -23.16 of the last 4 quarters.
The mean historical PE Ratio of UnicoCell Biomed Co., Ltd. over the last ten years is -34.94. The current -45.03 PE Ratio has changed 12.79% with respect to the historical average. Over the past ten years (40 quarters), 6794.TW's PE Ratio was at its highest in in the June 2019 quarter at -12.13. The PE Ratio was at its lowest in in the December 2024 quarter at -37.12.
Average
-34.94
Median
-35.03
Minimum
-53.78
Maximum
-21.31
Discovering the peaks and valleys of UnicoCell Biomed Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 57.01%
Maximum Annual PE Ratio = -21.31
Minimum Annual Increase = -24.60%
Minimum Annual PE Ratio = -53.78
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -43.55 | -19.02% |
| 2023 | -53.78 | 41.03% |
| 2022 | -38.14 | 4.19% |
| 2021 | -36.60 | 33.12% |
| 2020 | -27.50 | 9.01% |
| 2019 | -25.22 | -24.60% |
| 2018 | -33.45 | 57.01% |
The current PE Ratio of UnicoCell Biomed Co., Ltd. (6794.TW) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-45.16
5-year avg
-39.91
10-year avg
-34.94
UnicoCell Biomed Co., Ltd.’s PE Ratio is greater than Medigen Biotechnology Corp. (-68.22), less than Senhwa Biosciences, Inc. (-12.83), greater than Formosa Pharmaceuticals, Inc. (-69.19), less than Energenesis Biomedical CO.,LTD. (-13.21), less than AnnJi (-13.61), less than BRIM Biotechnology, Inc. (-15.89), less than TWi Biotechnology, Inc. (-10.78), less than Shine-On BioMedical Co.,Ltd. (-30.12), less than Sagittarius Life Science Corp (-41.86), less than Synbio Tech Inc. (17.04),
| Company | PE Ratio | Market cap |
|---|---|---|
| -68.22 | $4.25B | |
| -12.83 | $3.58B | |
| -69.19 | $4.23B | |
| -13.21 | $3.77B | |
| -13.61 | $4.33B | |
| -15.89 | $3.69B | |
| -10.78 | $2.05B | |
| -30.12 | $3.54B | |
| -41.86 | $3.22B | |
| 17.04 | $3.25B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like UnicoCell Biomed Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like UnicoCell Biomed Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is UnicoCell Biomed Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for UnicoCell Biomed Co., Ltd. (6794.TW)?
What is the highest PE Ratio for UnicoCell Biomed Co., Ltd. (6794.TW)?
What is the 3-year average PE Ratio for UnicoCell Biomed Co., Ltd. (6794.TW)?
What is the 5-year average PE Ratio for UnicoCell Biomed Co., Ltd. (6794.TW)?
How does the current PE Ratio for UnicoCell Biomed Co., Ltd. (6794.TW) compare to its historical average?